Myopia (short-sightedness) is rising fast among Australian children, and the good news is that we can now do far more than simply update glasses each year. At Mark Hinds Optometrists, we use evidence-based treatments designed to slow how quickly myopia progresses, protecting your child’s long-term eye health. Soft contact lenses have become one of the… Continue reading The Latest in Myopia Control Soft Contact Lenses
The Latest in Myopia Control Soft Contact Lenses
Tag: mark hinds optometrists
Orthokeratology: Latest Thinking in Myopia Control
Orthokeratology, often called Ortho-K, is one of the most established contact lens options for childhood myopia control. The lenses are worn overnight and gently reshape the front surface of the eye while sleeping. In the morning, the lenses are removed and most patients can see clearly throughout the day without glasses or daytime contact lenses.… Continue reading Orthokeratology: Latest Thinking in Myopia Control
Advancing Care for Patients with Sjögren’s Related Dry Eye Disease
Our care and research: At Mark Hinds Optometrists and Ophthalmic Trials Australia, our team is committed to improving the lives of patients living with severe dry eye disease, ocular surface inflammation, and autoimmune-related eye disease through advanced clinical care, research, and innovation. One important area of focus is Sjögren’s related dry eye disease — a… Continue reading Advancing Care for Patients with Sjögren’s Related Dry Eye Disease
Dr Rebecca Kitson at the J&J Contact Lens Leaders Summit in Sydney May 24-25 2026:
Enables us to be one of the First Practices in Australia to Offer the New J&J Daily Disposable Multifocal Toric Contact Lens At Mark Hinds Optometrists, we are proud to continue leading the way in advanced contact lens technology — becoming one of the first practices in Australia to fit the new Johnson & Johnson… Continue reading Dr Rebecca Kitson at the J&J Contact Lens Leaders Summit in Sydney May 24-25 2026:
Managing Your Practices Myopia Integration
Insight Magazine With an abundance of evidence, diagnostics and treatments, the bar has arguably never been lower for practices to incorporate myopia control. In fact, some contend there is a diminishing list of reasons for Optometrists not to practice some form of management. Insight speaks to Mark Hinds, Kevin Trac and Jenkin Yau about their… Continue reading Managing Your Practices Myopia Integration
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial
The Ocular Surface Volume 29, July 2023, Pages 537-546 Stephanie L. Watson, Lyndon W. Jones, Fiona Stapleton, Mark Hinds, Alison Ng, Jacqueline Tan, Yair Alster, Charles Bosworth, Omer Rafaeli, Venita DePuy, The CELESTIAL STUDY Group Over the past few years our own, Mark Hinds, with his team at Ophthalmic Trials Australia (www.ot-au.com) have been involved in the multi-centered investigation into the efficacy and safety of selenium sulfide ointment in the setting of meibomian gland dysfunction (MGD)… Continue reading Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial
MiYOSMART Spectacle Lenses for Myopia Control
The MiYOSMART spectacle lenses have been found to significantly reduce the progression of myopia and axial elongation in children in the UK, as compared to data from untreated myopes. The study looked at the change in spherical equivalent refraction (SER) and axial length (AL) over a period of 12 months in 87 children between the… Continue reading MiYOSMART Spectacle Lenses for Myopia Control
Myopia in Australian kids – an easy read
Myopia, commonly known as nearsightedness, is a growing concern in Australia, especially in children. Myopia occurs when the eye is longer than normal, causing light to focus in front of the retina instead of on it, leading to blurred vision. This can lead to a range of problems, such as difficulty reading or seeing distant… Continue reading Myopia in Australian kids – an easy read
Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops
ARVO Abstract Number: 812 – C0495 AuthorBlock: Matilda Biba1, Gareth Lingham1, Emmanuel Kobia-Acquah1, Ian Flitcroft1,2, James Loughman1 1Centre for Eye Research Ireland (CERI), Technological University Dublin, Dublin, Dublin, Ireland; 2Ophthalmology, Children’s Health Ireland at Temple Street, Dublin, Dublin, Ireland; Summary of paper : Myopia, also known as near sightedness, is a condition where a person can see nearby… Continue reading Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops
The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication
AZR-MD-001 restores gland gunction and improves signs and ocular symptoms of mebomian gland dysfunction (MGD) Posterboard#: B0072 Abstract Number: 5175 – B0072 AuthorBlock: Preeya Gupta1,2, Laura Elizabeth Downie3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Triangle Eye Consultants, Raleigh, North Carolina, United States; 2Ophthalmology, Tulane University, New Orleans, Louisiana, United States; 3Optometry and Vision Science, The University of Melbourne, Melbourne,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication